339 related articles for article (PubMed ID: 24139733)
1. A systematic review of current and emerging approaches in the field of larynx preservation.
Denaro N; Russi EG; Lefebvre JL; Merlano MC
Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
[TBL] [Abstract][Full Text] [Related]
2. Larynx preservation: what is the best non-surgical strategy?
Lagha A; Chraiet N; Labidi S; Rifi H; Ayadi M; Krimi S; Allani B; Raies H; Touati S; Boussen H; Kochbati L; Mezlini A
Crit Rev Oncol Hematol; 2013 Nov; 88(2):447-58. PubMed ID: 23755889
[TBL] [Abstract][Full Text] [Related]
3. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy for organ function preservation in advanced patients with hypopharyngeal and laryngeal cancer.
Kogashiwa Y; Yamauchi K; Nagafuji H; Matsuda T; Tsubosaka T; Tsutsumi T; Karaho T; Kohno N
Oncol Rep; 2009 Nov; 22(5):1163-7. PubMed ID: 19787235
[TBL] [Abstract][Full Text] [Related]
5. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
[TBL] [Abstract][Full Text] [Related]
7. [Larynx preservation: nonsurgical approaches].
Bourhis J; Lefebvre JL; Temam S; Lusinchi A; Janot F; Wibault P; Pignon JP
Cancer Radiother; 2004 Nov; 8 Suppl 1():S24-8. PubMed ID: 15679243
[TBL] [Abstract][Full Text] [Related]
8. [Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma].
Zhang X; Wang J; Wu W; Ma L; Liu M; Zhao F; Huang D
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):558-63. PubMed ID: 25257270
[TBL] [Abstract][Full Text] [Related]
9. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
[TBL] [Abstract][Full Text] [Related]
10. Long-term update of the 24954 EORTC phase III trial on larynx preservation.
Henriques De Figueiredo B; Fortpied C; Menis J; Lefebvre JL; Barzan L; de Raucourt D; Geoffrois L; Giurgea L; Hupperets P; Leemans CR; Licitra L; Rolland F; Tesselaar M; Vermorken JB; Grégoire V;
Eur J Cancer; 2016 Sep; 65():109-12. PubMed ID: 27494036
[TBL] [Abstract][Full Text] [Related]
11. Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.
Alterio D; Franco P; Numico G; Licitra L; Cossu Rocca M; Ferrari A; Pinto C; Russi EG; Ricardi U; Jereczek Fossa BA
Med Oncol; 2016 Jul; 33(7):76. PubMed ID: 27290695
[TBL] [Abstract][Full Text] [Related]
12. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
13. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
14. [Organ sparing treatment modalities - which type of treatment for which carcinoma?].
Kornek GV; Selzer E
Wien Med Wochenschr; 2008; 158(9-10):264-9. PubMed ID: 18560952
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
16. [Organ preservation in laryngeal and hypopharyngeal cancer].
Quer M; León X
Acta Otorrinolaringol Esp; 2007 Dec; 58(10):476-82. PubMed ID: 18082078
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
Forastiere AA; Zhang Q; Weber RS; Maor MH; Goepfert H; Pajak TF; Morrison W; Glisson B; Trotti A; Ridge JA; Thorstad W; Wagner H; Ensley JF; Cooper JS
J Clin Oncol; 2013 Mar; 31(7):845-52. PubMed ID: 23182993
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
Pignon JP; Bourhis J; Domenge C; Designé L
Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
[TBL] [Abstract][Full Text] [Related]
20. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
